Company intelligence / Profile preview

ACS Global

Lyon, Auvergne-Rhone-Alpes, France

Ownership: Private
Employees: ~2
Development stage: Other

Overview

ACS Biotech developed an injectable cartilage repair solution using chitosan (a natural, biodegradable, and biocompatible polymer) combined with cartilage cells, administered via mini-invasive arthroscopic surgery

Therapeutic areas: Rheumatology
Modalities: Cell therapyBiologic
Industry: Biotech

Partnerships

EIT Health-supported project

Beyond the preview

Go deeper on ACS Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACS Global.

Explore the full profile